Corporate governance and financial performance - a study of the Indian drug and pharmaceutical industry Online publication date: Thu, 08-Sep-2022
by Avani Shah; Udai Lal Paliwal
International Journal of Economics and Business Research (IJEBR), Vol. 24, No. 3, 2022
Abstract: Issues surrounding corporate governance practices assumed greater significance over the past few decades as research has proven that good corporate governance significantly influence performance of companies. Using panel data from 90 listed companies of the Indian drug and pharmaceutical industry for a period of five years (2015 to 2019), the present paper analyses the influence of corporate governance on financial performance of the sample companies. Return on assets (ROA) and return on capital employed (ROCE) were used to measure financial performance. The study revealed a mixed impact as promotor shareholdings, CEO duality and firm size were positively and significantly related to firm's financial performance, however, board independence, board size, leverage and liquidity were found not to have a significant impact. This study is useful as it provides some useful insights on the envisaged relationship in a specific context of the Indian drug and pharmaceutical industry.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Economics and Business Research (IJEBR):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook